Renaissance Technologies’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $661K | Sell |
|
|||||
|
2025
Q1 | $843K | Sell |
|
|||||
|
2024
Q4 | $2.09M | Buy |
|
|||||
|
2024
Q3 | $2.04M | Sell |
|
|||||
|
2024
Q2 | $1.03M | Sell |
|
|||||
|
2024
Q1 | $1.13M | Buy |
|
|||||
|
2023
Q4 | $1.03M | Buy |
|
|||||
|
2023
Q3 | $616K | Sell |
|
|||||
|
2023
Q2 | $1.12M | Sell |
|
|||||
|
2023
Q1 | $460K | Sell |
|
|||||
|
2022
Q4 | $551K | Sell |
|
|||||
|
2022
Q3 | $798K | Buy |
|
|||||
|
2022
Q2 | $953K | Buy |
|
|||||
|
2022
Q1 | $1.48M | Sell |
|
|||||
|
2021
Q4 | $2.52M | Buy |
|
|||||
|
2021
Q3 | $2.97M | Sell |
|
|||||
|
2021
Q2 | $1.76M | Sell |
|
|||||
|
2021
Q1 | $2.04M | Sell |
|
|||||
|
2020
Q4 | $2.84M | Sell |
|
|||||
|
2020
Q3 | $3.51M | Sell |
|
|||||
|
2020
Q2 | $2.81M | Buy |
|
|||||
|
2020
Q1 | $1.96M | Buy |
|
|||||
|
2019
Q4 | $4.93M | Buy |
|
|||||
|
2019
Q3 | $2.56M | Buy |
|
|||||
|
2019
Q2 | $3.12M | Buy |
|
|||||
|
2019
Q1 | $3.14M | Buy |
|
|||||
|
2018
Q4 | $2.43M | Buy |
|
|||||
|
2018
Q3 | $3.4M | Buy |
|
|||||
|
2018
Q2 | $3.57M | Sell |
|
|||||
|
2018
Q1 | $4.92M | Buy |
|
|||||
|
2017
Q4 | $2.43M | Buy |
|
|||||
|
2017
Q3 | $3.1M | Buy |
|
|||||
|
2017
Q2 | $1.66M | Buy |
|
|||||
|
2017
Q1 | $1.2M | Buy |
|